Blakeslea trispora producing high yield of lycopene in a suitable medium in the absence of an exogenous carotenogenesis inhibitor
CA 2465267 A1 · Owner: Dsm Ip Assets B.V. · Inventors: Schaap, Albert; Voronina, Lilia Nikolaevna; Morozova, Elena Sergeevna
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to Blakeslea trispora (B. trispora) strains producing at least 0.3 g/l lycopene, when co-cultivated for at least three days with a suitable strain of Blakeslea trispora of the opposite mating type in a suitable medium in the absence of an exogenous cartenogenesis inhibitor to a , natural efficient production process of lycopene by these strains to a growth , medium highly suited for this process and to an isolation process suited for any carotenoid compound.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.